reviewAmerican Journal of TherapeuticsJan 1, 2005Closed access

Mechanism of Action of Paracetamol

GGGarry G. GrahamKFKieran F. Scott

UNSW Sydney · St Vincent's Hospital Sydney

PubMed
Indexed incrossrefpubmed

Abstract

Paracetamol (acetaminophen) is generally considered to be a weak inhibitor of the synthesis of prostaglandins (PGs). However, the in vivo effects of paracetamol are similar to those of the selective cyclooxygenase-2 (COX-2) inhibitors. Paracetamol also decreases PG concentrations in vivo, but, unlike the selective COX-2 inhibitors, paracetamol does not suppress the inflammation of rheumatoid arthritis. It does, however, decrease swelling after oral surgery in humans and suppresses inflammation in rats and mice. Paracetamol is a weak inhibitor of PG synthesis of COX-1 and COX-2 in broken cell systems, but, by contrast, therapeutic concentrations of paracetamol inhibit PG synthesis in intact cells in vitro when…

Citation impact

634
total citations
FWCI
16.01
Percentile
100%
References
75
Citations per year

Authors

2

Topics & keywords

Keywords
  • Medicine
  • Mechanism (biology)
  • Action (physics)
  • Mechanism of action
  • Pharmacology
  • Intensive care medicine
  • Epistemology
  • Genetics
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding